IN8bio, Inc.
INAB
$1.80
-$0.11-5.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 36.13% | 35.19% | 25.25% | 11.66% | -1.43% |
| Total Depreciation and Amortization | -5.80% | 3.95% | 12.14% | 5.86% | 6.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.79% | -39.64% | -9.85% | -2.42% | 15.45% |
| Change in Net Operating Assets | 173.51% | 106.27% | -923.64% | 1,164.29% | -592.16% |
| Cash from Operations | 47.36% | 41.53% | 30.05% | 18.76% | -3.47% |
| Capital Expenditure | -- | 85.40% | 89.11% | 52.07% | 68.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 85.40% | 89.11% | 52.07% | 68.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 12.72% | -7.09% | -15.56% | -2.47% | 0.50% |
| Issuance of Common Stock | 94.67% | 26.42% | 11.43% | -29.26% | -45.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 167.04% | 100.00% | 100.00% | -- |
| Cash from Financing | 101.90% | 30.50% | 11.80% | -30.00% | -47.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 256.88% | 175.75% | 144.62% | -151.62% | -427.06% |